Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001583648-25-000013
Filing Date
2025-02-07
Accepted
2025-02-07 16:29:59
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3805
  Complete submission text file 0001583648-25-000013.txt   6149
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Reporting) CIK: 0001583648 (see all company filings)

State of Incorp.: NV | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 25602256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)